Welcome to the Personalized Diagnostics Podcast. We are going to be talking to some of the greatest minds and personalities in the diagnostics space – the engine which is driving personalized medicine forward. We will be exploring the unmet need for better diagnostics across the patient journey - from screening to treatment to treatment monitoring, new assay development, technologies such as next generation sequencing and artificial intelligence plus we’ll be tackling issues in reimbursement and health economics- how we’re going to pay for all this and how diagnostics can provide value to the health care system. Thanks for listening.
What can we learn from previous pandemics to apply to the current situation? What do we actually know to be true about the novel coronavirus? Jeffrey ...
Change can be slow - particularly in #healthcare. Establishing clinical validity and clinical utility can be slow. Getting regulatory approvals can be...
Since the human genome has been sequenced, it has become clear that the technology to sequence has far outstripped our capabilities to accurately clas...
We have seen tremendous advances in sequencing technology. And the cost to sequence is going to zero, according to Moore's Law. More and more genes an...
"We have to evolve." Establishing a "gold standard" for real world evidence will allow us to move beyond what we can learn from the 4% of patients enr...
Fewer than 4% of oncology patients ever make it onto a clinical trial. And these 4% may not even reflect the real-world patient experience. How can we...
There’s no question that we are awash in promising new technologies with the potential to advance precision medicine. But is the existing infrastructu...
There’s no question that we are awash in promising new technologies with the potential to advance precision medicine. But is the existing infrastructu...
The diagnostics #industry is very fragmented, in terms of testing laboratories, test developers, and testing methodologies used. Companion diagnostics...
